Modulating the p53 pathway
- PMID: 20193765
- DOI: 10.1016/j.semcancer.2010.02.004
Modulating the p53 pathway
Abstract
p53 is a transcription factor that protects cells against stress, by modulating genes that induce growth arrest, repair, apoptosis, senescence or altered metabolism. Activation of p53 can potentially be used to modulate disease states. We describe here recent developments that attempt to modulate the function of p53 and outline strategies that are being investigated for pharmacological intervention in the p53 pathway. These include interruption of the interactions between p53 and its negative regulators, restabilization of mutant/misfolded p53, activation of p53 dependant transcription and modulation of p53 function systemically to affect the therapeutic profile of existing drugs. In addition the development of new animal models to investigate the above developments, including mice and zebrafish will be highlighted.
Copyright (c) 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Current strategies to target p53 in cancer.Biochem Pharmacol. 2010 Sep 1;80(5):724-30. doi: 10.1016/j.bcp.2010.04.031. Epub 2010 May 5. Biochem Pharmacol. 2010. PMID: 20450892 Review.
-
Classic and novel roles of p53: prospects for anticancer therapy.Trends Mol Med. 2007 May;13(5):192-9. doi: 10.1016/j.molmed.2007.03.002. Epub 2007 Mar 23. Trends Mol Med. 2007. PMID: 17383232 Review.
-
Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 4: p53 signaling pathway.Expert Rev Anticancer Ther. 2005 Feb;5(1):177-91. doi: 10.1586/14737140.5.1.177. Expert Rev Anticancer Ther. 2005. PMID: 15757449 Review.
-
[p53-regulating pathways as targets for personalized cancer therapy].Dtsch Med Wochenschr. 2013 Jan;138(3):82-6. doi: 10.1055/s-0032-1327380. Epub 2013 Jan 8. Dtsch Med Wochenschr. 2013. PMID: 23299342 Review. German.
-
The genetics of the p53 pathway, apoptosis and cancer therapy.Nat Rev Drug Discov. 2008 Dec;7(12):979-87. doi: 10.1038/nrd2656. Nat Rev Drug Discov. 2008. PMID: 19043449 Review.
Cited by
-
Mice with a Mutation in the Mdm2 Gene That Interferes with MDM2/Ribosomal Protein Binding Develop a Defect in Erythropoiesis.PLoS One. 2016 Apr 4;11(4):e0152263. doi: 10.1371/journal.pone.0152263. eCollection 2016. PLoS One. 2016. PMID: 27042854 Free PMC article.
-
Value of glycogen synthase 2 in intrahepatic cholangiocarcinoma prognosis assessment and its influence on the activity of cancer cells.Bioengineered. 2021 Dec;12(2):12167-12178. doi: 10.1080/21655979.2021.2005224. Bioengineered. 2021. PMID: 34783271 Free PMC article.
-
Panhistone deacetylase inhibitors inhibit proinflammatory signaling pathways to ameliorate interleukin-18-induced cardiac hypertrophy.Physiol Genomics. 2011 Dec 16;43(24):1319-33. doi: 10.1152/physiolgenomics.00048.2011. Epub 2011 Sep 27. Physiol Genomics. 2011. PMID: 21954451 Free PMC article.
-
Restoration of DNA-binding and growth-suppressive activity of mutant forms of p53 via a PCAF-mediated acetylation pathway.J Cell Physiol. 2010 Nov;225(2):394-405. doi: 10.1002/jcp.22285. J Cell Physiol. 2010. PMID: 20589832 Free PMC article.
-
Post-translational modification in the pathogenesis of vitiligo.Immunol Res. 2024 Dec;72(6):1229-1237. doi: 10.1007/s12026-024-09545-x. Epub 2024 Sep 25. Immunol Res. 2024. PMID: 39320694 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous